Company news
Cizzle Biotechnology Holdings PLC news in 2022
Cizzle Biotechnology Holdings PLC's news releases, calls and decks from 2022, newest first.
Update re. timing of Admission
December 20, 2022
Put Option re AZD1656 & £115,586 Subscription
December 19, 2022
Clinical Study for Lung Cancer Detection in China
November 23, 2022
Conduit Pharmaceuticals Proposed Listing
November 9, 2022
Admission and Total Voting Rights
October 4, 2022
Issue of Consideration Shares & Option Exercise
September 29, 2022
Interim results
September 28, 2022
Subscription, Facility & Publication of Prospectus
September 21, 2022
Arcadia Clinical Trial Results Published
August 18, 2022
Cizzle Biotechnology (CIZ): Considerable progre...
July 11, 2022
Update on Development of Proprietary Antibodies
July 5, 2022
Marketing Agreement to Enhance Expansion in the US
June 16, 2022
Results for the year ended 31 December 2021
May 30, 2022
Strategic Alliance re lung cancer detection in USA
May 6, 2022
Further Research Agreement with University of York
April 11, 2022
Positive outcomes from Arcadia Trial re AZD1656
March 7, 2022
Royalty Acquisition Agreement
February 14, 2022
Cizzle Biotechnology (CIZ) Strategic alliance i...
February 8, 2022
China Royalty Agreement for Lung Cancer Detection
February 3, 2022